TimesSquare Capital Management LLC Purchases 48,207 Shares of Addus HomeCare Corporation $ADUS

TimesSquare Capital Management LLC increased its holdings in shares of Addus HomeCare Corporation (NASDAQ:ADUSFree Report) by 13.9% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 394,047 shares of the company’s stock after purchasing an additional 48,207 shares during the period. TimesSquare Capital Management LLC’s holdings in Addus HomeCare were worth $45,390,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. BI Asset Management Fondsmaeglerselskab A S bought a new position in Addus HomeCare in the 1st quarter worth approximately $41,000. CWM LLC grew its stake in shares of Addus HomeCare by 25.3% in the second quarter. CWM LLC now owns 554 shares of the company’s stock worth $64,000 after acquiring an additional 112 shares during the last quarter. Parkside Financial Bank & Trust increased its position in Addus HomeCare by 22.9% during the second quarter. Parkside Financial Bank & Trust now owns 661 shares of the company’s stock worth $76,000 after acquiring an additional 123 shares during the period. Caitong International Asset Management Co. Ltd raised its stake in Addus HomeCare by 368.3% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,255 shares of the company’s stock valued at $124,000 after purchasing an additional 987 shares during the last quarter. Finally, Assetmark Inc. boosted its holdings in Addus HomeCare by 24.5% in the 2nd quarter. Assetmark Inc. now owns 1,286 shares of the company’s stock valued at $148,000 after purchasing an additional 253 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Cowen reaffirmed a “buy” rating on shares of Addus HomeCare in a research report on Wednesday, November 5th. Stephens reiterated an “overweight” rating and issued a $140.00 price objective on shares of Addus HomeCare in a research report on Wednesday, September 3rd. JMP Securities reissued a “market outperform” rating and set a $150.00 price objective on shares of Addus HomeCare in a report on Wednesday, July 16th. Barclays boosted their price objective on Addus HomeCare from $111.00 to $117.00 and gave the company an “underweight” rating in a research report on Tuesday, November 4th. Finally, UBS Group initiated coverage on Addus HomeCare in a research report on Tuesday, September 2nd. They issued a “buy” rating and a $145.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Addus HomeCare currently has an average rating of “Moderate Buy” and an average target price of $139.25.

Get Our Latest Report on ADUS

Insider Activity

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $114.95, for a total value of $2,873,750.00. Following the transaction, the chief executive officer directly owned 166,461 shares in the company, valued at approximately $19,134,691.95. This trade represents a 13.06% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Brian Poff sold 7,739 shares of the company’s stock in a transaction on Monday, August 25th. The shares were sold at an average price of $116.82, for a total value of $904,069.98. Following the transaction, the executive vice president directly owned 56,980 shares in the company, valued at $6,656,403.60. This trade represents a 11.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 34,310 shares of company stock valued at $3,958,375 over the last three months. 4.50% of the stock is owned by insiders.

Addus HomeCare Stock Up 1.5%

Shares of ADUS opened at $114.51 on Wednesday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.74 and a quick ratio of 1.74. The company has a market capitalization of $2.12 billion, a P/E ratio of 25.28, a PEG ratio of 1.87 and a beta of 0.88. The business’s 50 day simple moving average is $115.24 and its 200-day simple moving average is $112.97. Addus HomeCare Corporation has a one year low of $88.96 and a one year high of $136.72.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last announced its earnings results on Monday, November 3rd. The company reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.53 by $0.03. The company had revenue of $362.30 million during the quarter, compared to analyst estimates of $354.48 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The firm’s quarterly revenue was up 25.0% compared to the same quarter last year. During the same period last year, the company posted $1.30 earnings per share. As a group, sell-side analysts predict that Addus HomeCare Corporation will post 4.59 EPS for the current fiscal year.

About Addus HomeCare

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

See Also

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.